Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.

A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells¹

2010 • 4,125 citations

Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered <italic>In Vivo</italic><xref ref-type="fn" rid="FN2">2</xref>

1966 • 537 citations

Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine.

1968 • 477 citations

A Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo

1963 • 401 citations

The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)

1968 • 296 citations

The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.

1970 • 209 citations

Cell cycle phase specificity of antitumor agents.

1972 • 150 citations

Interference of daunomycin with metabolic events of the cell cycle in synchronized cultures of rat fibroblasts.

1970 • 50 citations

Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia

1973 • 46 citations

Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.

1972 • 34 citations

Kinetics of the lethal effect of actinomycin D on normal and leukemic cells.

1973 • 26 citations